According to Future Market Insights’ most recent estimate of the global hospital-acquired infection control industry, sales of this product will reach US$ 6.5 billion globally in 2023. The market is anticipated to reach US$ 12.7 billion by 2033 with a CAGR of 7% between 2023 and 2033. Hospitals and Intensive Care Units are anticipated to …
Category Archives: Healthcare Trends
Global Monkeypox Treatment Industry, as projected by FMI, is set for significant growth, aiming at US$ 249 Million by 2033
A recent Future Market Insights report on the global monkeypox treatment industry forecasts that demand is expected to rise at a CAGR of 10.25% from 2023 to 2033. The global monkeypox treatment market is expected to reach a valuation of US$ 93.84 million in 2023 and as per the findings, a valuation of US$ 249 million is expected for …
Global Nasal Polyposis Treatment Market is on track for a 6.7% CAGR surge, guided by progressive strategies per FMI’s analysis
According to a recently released study by Future Market Insights, the global nasal polyposis treatment market is anticipated to reach US$ 4.6 billion in value by 2023-end and is likely to grow at a CAGR of 6.7% until 2033. A market valuation of US$ 8.8 billion is anticipated by the conclusion of the projected period. …
Preoperative Bathing Solution Market Forecasts a Valuation of US$ 5.4 Billion by 2033-FMI Study
The preoperative bathing solution market is projected to reach a valuation of US$ 3.5 billion by 2023. It is anticipated that the market will grow at a 4.6% CAGR to reach US$ 5.4 billion by 2033. The preoperative bathing solution market is growing for a number of reasons, including growing awareness of surgical infections and its expansion …
Procalcitonin (PCT) Assay Market Skyrockets to US$ 512.9 Million by 2033-FMI Study
The global procalcitonin (PCT) assay market is on a trajectory of substantial growth, with a projected market size of US$ 280.6 million in 2023 and an anticipated CAGR of 6.2% during the forecast period, propelling it to a valuation of US$ 512.9 million by 2033. One of the key drivers for this growth is the …
Pulmonary Fibrosis Biomarkers Market Anticipates a Remarkable Valuation of US$ 6.2 Billion by 2033-FMI Study
The global Pulmonary Fibrosis Biomarkers Market is on a trajectory of substantial growth, with a projected market size of US$ 4.1 billion in 2023 and an anticipated CAGR of 4.2% during the forecast period, propelling it to a valuation of US$ 6.2 billion by 2033. Key to this growth is the rapid advancement in pulmonary fibrosis biomarkers, …
Pulsed Field Ablation (PFA) Market Set to Surge Beyond US$ 11.7 Million by 2033-FMI Study
The global Pulsed Field Ablation (PFA) Market is poised for remarkable growth, with projections indicating a substantial leap from US$ 1.3 million in 2023 to over US$ 11.7 million by 2033, at a remarkable CAGR of 24.2% during this ten-year period. Pulsed Field Ablation is an innovative, catheter-based technique that has been revolutionizing the treatment of cardiac …
Global Head and Neck Cancer (HNC) Therapeutics Market growth is on track to reach US$ 5.19 Billion by 2033, supported by a CAGR of 12.6%
The global head and neck cancer (HNC) therapeutics market is anticipated to surpass a remarkable worth of US$ 1.58 Billion in 2023, is expected to surpass an impressive valuation of US$ 5.19 Billion by 2033 with a compound annual growth rate (CAGR) of 12.6% from 2023 to 2033. Developments in the detection and treatment of head and …
Global Eosinophilic Granulomatosis with Polyangiitis Treatment Market is on track to achieve US$ 288.5 Million by 2033, according to a study by FMI
The global Eosinophilic Granulomatosis With Polyangiitis Treatment Market is currently valued at US$ 173.8 Million in 2023 and is anticipated to expand at a CAGR of 5.2%. Owing to the technological advances in healthcare the market is likely to propel to US$ 288.5 Million by 2033. The growing occurrences of churg strauss syndrome and other allergic reactions and …
Global Oncology-based In-Vivo CRO Market is estimated to grow to US$ 2.9 Billion by 2033, with a CAGR of 10.9%, as per FMI’s analysis
The global oncology-based in-vivo CRO market is worth US$ 1.1 Billion as of now and is expected to reach US$ 2.9 Billion by the year 2033 at a notable CAGR of 10.9% between 2023 and 2033. The WHO states that as of the year 2020, 19.3 Million novel cases of cancer were reported along with …